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The links between low-dose range taxol-induced mitotic arrest and the subsequent engagement of apoptosis are important for
identifying the routes to therapeutic action. Here we have investigated the timing of cell-cycle perturbation and cell death responses
following continuous exposure to clinically relevant drug concentrations (1–20nM). Following 8h of exposure to taxol, the cell line
DoHH2 (p53 wild type) exhibited mitotic arrest and engagement of apoptosis, whereas the cell line SU-DHL-4 (p53 mutant)
breached cell-cycle arrest with progression to an abnormal cycle and a 24h delay in the engagement of apoptosis. Imaging showed
equivalent dysfunction of mitotic spindles in both cell lines. The results of kinetic analyses indicated that although cell death may occur
at different stages of progression through mitosis and subsequent cell cycles, the overall kinetics of cell death relate to the rate of
arrival at a critical event window in the cell cycle. We propose a simple model of low-dose taxol-induced cell death for cycling
populations in which mitotic stress acts as a primary trigger for apoptosis with equivalent but potentially delayed outcomes. This view
provides a rationale for the clinical effectiveness of this agent, independent of the initial capacity of the tumour cell to engage
apoptosis due, for example, to mutant p53 expression. The results provide a perspective for the design of combination regimens that
include low-dose taxol and a component that may disturb mitotic delivery.
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Paclitaxel (taxol) is a complex diterpenoid isolated from the inner
bark of the Western yew tree – Taxus brevifolia (Wani et al, 1971).
This naturally occurring agent has been shown to have significant
activity against advanced ovarian cancers (McGuire et al, 1989;
Runowicz et al, 1995), metastatic breast cancers (Holmes et al,
1991; Hortobagyi and Holmes, 1996), and leukaemias (Rowinsky
et al, 1989) refractory to standard chemotherapy. It has also shown
some activity against various other tumour types (Etlinger, 1993;
Forastiere, 1993; Einzig and Wiernik, 1995; Edelman and Gandara,
1996). Although the mechanism by which stable microtubules are
induced by taxol are well established (Schiff et al, 1979; Rao et al,
1992, 1994), the molecular links between tubulin polymerisation,
cell-cycle arrest, and ultimately cell death are not so well
characterised. Given the broad spectrum of activity of taxol with
regard to tumour type and genetic background, it is important that
these mechanisms are resolved. In particular, whether a mitotic
arrest is essential for taxol-induced cell death and if so does a
functional spindle checkpoint affect survival outcome. Many
successful cancer treatments rely upon combinations of therapeu-
tic agents, and it is important for the development of such
regimens so that the mechanism and the complex kinetics of
cellular response to taxol are clarified. In particular, combination
with agents that have different cell-cycle specificities may produce
effects that abrogate taxol action.
Taxol appears to target microtubules specifically both in vitro
and in vivo (Schiff and Horwitz, 1980, 1981; Manfredi et al, 1982;
Manfredi and Horwitz, 1984; De Brabender et al, 1996). However,
unlike classical antimicrotubule agents, such as colchicine and
vinblastine, that induce microtubule disassembly and paracrystal
formation (Wilson et al, 1974), the antitumour activity of taxol has
been demonstrated to be associated with microtubule stabilisation
(Manfredi and Horwitz, 1984; Horwitz et al, 1986) and with the
arrest of cells in the G2/M phase of the cell cycle (Rowinsky et al,
1990; Slichenmyer and von Hoff, 1991; Rowinsky et al, 1992). In
addition to stabilising microtubules and inducing cell-cycle arrest,
taxol has also been demonstrated to induce apoptosis in a variety
of solid tumour cells (Cheng et al, 1995; Jordan et al, 1996; Milross
et al, 1996). However, the dependence of taxol-induced cell death
on cell-cycle-specific arrest is not clear. Apoptosis is an important
factor in describing population responses to DNA damage and
is related in part to p53 function. For example, while wild-type
p53 cells undergo apoptosis after exposure to radiation, p53
mutant cells show delays in the progression to apoptosis (Lowe
et al, 1993b). Dysfunction of p53-dependent pathways can allow
tumour cells to evade the checkpoint controls and apoptosis,
thereby gaining a selective advantage in attempting to overcome
therapy (Lowe et al, 1993a). As a consequence, cancers with TP53
mutations tend to have a worse prognosis for responses to
chemotherapy than those showing wild-type alleles (Callahan,
1992).
The situation regarding the role of TP53 dysfunction in the
response of tumour cells to taxol is more complicated with several
contradictory reports appearing in the literature. One report
describes that in different cultured fibroblast cell lines, disruption
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sof wild-type p53 function resulted in increased sensitivity of cells
to taxol treatment compared to cells expressing wild-type p53
(Wahl et al, 1996). Conversely in an ovarian cancer cell line
expressing wild-type p53, the disruption of p53 by transfection
with the E6 protein of human papilloma virus type 16 led to a
decrease in sensitivity to taxol (Wu and El-Deiry, 1996). It has also
been reported that the introduction of wild-type p53 into an
ovarian cancer cell line not expressing p53 resulted in no change to
the tumour cell sensitivity to taxol (Graniela Sire et al, 1995). The
situation is further complicated with taxol being reported to
increase the levels of p53 protein in some cell types (Tishler et al,
1995) but not in others (Graniela Sire et al, 1995).
Regardless of p53 status, the sequence of signals triggering the
apoptotic response may also be dependent upon taxol concentra-
tion. Thus, when cells are exposed to low concentrations of taxol
(1–100nM), which do not affect the overall cytoskeletal micro-
tubule structures (Jordan et al, 1993), it has been proposed that
triggering of the mitotic spindle checkpoint promotes arrest and
apoptosis directly (Sorger et al, 1997). The mitotic spindle
checkpoint is a signal transduction pathway that links a
kinetochore-associated sensor, which monitors the appropriate
connection between mitotic spindles and chromosomes, to an
output that arrests the cell cycle (Sorger et al, 1997). Several
mammalian gene products have been identified to function at the
spindle assembly checkpoint including the Mad (mitotic arrest
defective) proteins Mad 1-3, the Bub (budding uninhibited by
benomyl) proteins, Bub 1-3 and Mps1. Treatment with taxol
or nocodozole upregulates Bub3 (Martinez-Exposito et al, 1999)
and expression of dominant-negative Bub1 inhibits nocadazole-
induced apoptosis (Taylor and McKeon, 1997), suggesting that
protracted activation of these gene products may play a role in
apoptosis induction following a mitotic arrest. It has also been
proposed that abnormal mitotic exit provides the signal for
apoptosis (Jordan et al, 1996). Wang et al (2000), suggesting that
these two events are the two possible triggers for cell death
following mitotic arrest or delay. Our hypothesis was that arrival of
cells at this critical cell-cycle phase is the ‘event’ that triggers
processes that end in cell death, although timing of the overt
expression of cell death will depend upon genetic status. Thus, the
rate of delivery to that event window determines future expression
of cell death, and the cell-cycle position at which cell death actually
occurs may be misleading in terms of event linkage.
This study was designed to identify the links between mitotic
arrest, and subsequent engagement of apoptosis, by investigating
the timing of these responses following exposure to clinically
relevant concentrations of taxol and over a sufficiently long period
to identify fully response outcomes. This is important since
different routes of taxol evasion prior to commitment to cell death
could provide routes for drug resistance phenotype development.
We have used two cell lines that represent different extremes of the
apoptotic responses to taxol in a multiparameter flow cytometric
study, which delineated cell-cycle traverse and correlated land-
mark cell-cycle events with the subsequent engagement and
kinetics of apoptosis. Cell-cycle landmarks were confirmed using
dual parameter measurements of DNA and either cyclin B1 (Gong
et al, 1995; Widrow et al, 1997) or the mitosis-specific protein
MPM2 (Juan et al, 2001).
MATERIALS AND METHODS
Cell lines and culture conditions
Two human follicular B-lymphoma cell lines were used in this
study. DoHH2 was a kind gift from Dr JC Kluin-Nelemans [Leiden,
The Netherlands; (Kluin-Nelemans et al, 1991)], and SU-DHL-4
was provided by Professor FE Cotter (Epstein et al, 1978). DoHH2
was routinely maintained in RPMI 1640 supplemented with 5%
FCS. SU-DHL-4 was cultured in RPMI 1640 supplemented with
10% FCS. All growth media were supplemented with 100Uml
 1
penicillin, 100mgml
 1 streptomycin, and 2mM glutamine. The
cells were passaged twice weekly at an initiating density of
5 10
4cellsml
 1 cultured at 371C in a humidified atmosphere of
5% CO2/95% air. The p53 status of DoHH2 (wild-type radiation
response) and SU-DHL-4 (stabilised mutant) was confirmed by
immunoblotting.
Irradiation
All irradiations were performed at room temperature in oxic
conditions using a
137Cs gamma source of 0.66MeV energy. The
dose rate was 1.2Gymin
 1. Irradiations were usually completed
within 10min.
Flow cytometry
Flow cytometric analyses were performed using a standard
configuration FACScan equipped with an argon-ion laser (Becton
Dickinson, Oxford, UK). Data from either 6000 or 10000 cells were
recorded using CellQuest software (Becton Dickinson, Oxford,
UK). Data analysis was performed using WinMDI (J Trotter,
Scripps Research Institute, San Diego, USA). Cell debris was
excluded from all the measurements on the basis of forward and
orthogonal light scatter. In the case of DNA analysis, cell
aggregates were excluded on the basis of pulse-width vs pulse-
area measurements of propidium iodide fluorescence. Normal
human lymphocytes were used to monitor instrument perfor-
mance and calibrate measurements of cellular DNA content.
Single parameter DNA measurements
Cell cultures were resuspended in phosphate-buffered saline (PBS).
A volume of 125ml of propidium iodide (0.4mgml
 1)/Triton X-
100 (1%vv
 1) was added to 1ml of cell suspension together with
50ml Ribonuclease A (10mgml
 1) (Sigma, Poole, UK). Cells were
incubated at 371C for 10min prior to FACS analysis. Normal
human lymphocytes were used to monitor instrument perfor-
mance and to calibrate measurements of DNA ploidy. Where
required, DNA histograms were deconvoluted according to the
protocol of Watson et al (1987) and Ormerod et al (1987).
Annexin-V–FITC measurements
In total, 0.5ml cells (5 10
5 cells) were labelled using an Annexin-
V–FITC labelling kit (Calbiochem-Novabiochem, Nottingham,
UK). Briefly, cells were labelled directly in the culture medium
using 1.25ml Annexin-V–FITC and 10ml of the supplied media
binding reagent for 15min at room temperature in the dark. Cells
were centrifuged at 250g for 5min and resuspended in 0.5ml of
binding buffer (10mM HEPES pH 7.4, 150mM NaCl, 2.5mM CaCl2,
1m M MgCl2, 4% BSA). A volume of 10ml propidium iodide
(30mgml
 1) was added and the samples analysed immediately by
flow cytometry.
Dual parameter cyclin B1/DNA and mitotic proteins/DNA
measurements
Approximately 5 10
5 cells were collected for each sample. Cells
were washed with cold PBS, fixed in ice-cold 70% ethanol, and then
stored overnight at 41C. Cells were washed in PBS and resuspended
in 100ml PBS containing 1% bovine serum albumin (BSA). A
volume of 10ml anti-cyclin B1 mouse monoclonal antibody (Dako,
Ely, UK) or 10ml anti-mitotic proteins (clone MPM2) mouse
monoclonal antibody (Dako, Ely, UK) was added and the cells
stored overnight at 41C. Cells were washed twice in PBS and
resuspended in 100ml PBS containing 1% BSA. A volume of 10ml
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santi-mouse IgG–FITC monoclonal antibody (Dako, Ely, UK) was
added and the cells incubated for 1h at room temperature in the
dark. Cells were washed twice in PBS to remove excess antibody
and resuspended in 1ml propidium iodide (10mgml
 1). A volume
of 50ml of RNAse (10mgml
 1) was added and the cells incubated
for 30min at room temperature prior to FACS analysis.
Microtubules immunocytochemistry
Approximately 10
6 cells were collected for each sample. Cells were
washed with cold PBS, fixed in 4% paraformaldehyde, and then
stored overnight at 41C. Cells were washed in PBS and rehydrated
in PBS for 10min at room temperature. Cells were permeabilised
in 0.1% Triton X-100/PBS for 30min at room temperature.
Nonspecific antibody labelling was blocked using goat serum
(1:10 dilution) for 1h at room temperature. Anti-b-tubulin
monoclonal antibody (clone TUB 2.1) (Sigma, UK) was added
(1:200 dilution) for 1h at 371C. Cells were washed four times to
remove excess antibody. Goat-anti-mouse IgG-Cy3 monoclonal
antibody (Amersham Pharmacia, Cardiff, UK) was added (1:100
dilution) for 30min at 371C. Cells were washed three times in PBS
to remove excess antibody. DNA was labelled using the red
fluorescent probe DRAQ5 (Biostatus Ltd, Shepshed, UK) (Smith
et al, 2000a). Cells were loaded with 10mM DRAQ5 for 10min at
room temperature and mounted without further washing.
Confocal laser scanning microscopy
A single optical slice dual channel image was acquired using a
confocal laser scanning microscope (CLSM) (BioRad Micro-
sciences Ltd, Hemel Hempsted, UK), equipped with a krypton/
argon ion laser and attached to a Zeiss Axiovert 135. DRAQ5
(DNA) was visualised using 647nm excitation and detected at 680/
30nm. Cy3 (tubulin) was excited at 568nm and detected at 590/
40nm.
RESULTS
DNA damage response and cell-cycle checkpoint status
The two cell lines SU-DHL-4 and DoHH2 both grow in suspension
culture with doubling times of approximately 17 and 21h,
respectively. To establish whether the two cell lines exhibit the
expected differential pattern of cell-cycle arrest in response to
ionising radiation (based upon their known p53 status), cultures
were exposed to 4Gy of g-irradiation (preliminary observations
indicated that this dose was suitable for inducing cell-cycle arrest
without inducing a substantial cell kill). Figure 1 shows the typical
changes in cell-cycle distribution of irradiated DoHH2 and
SU-DHL-4 cells with a postirradiation incubation period of 14h.
The DoHH2 cell line exhibits a retention of cells in G1 and an
accumulation in G2 with a simultaneous reduction in the number
of cells in S phase, typical of a wild-type p53 response (Kuerbitz
et al, 1992). In contrast, the SU-DHL-4 cells lack a G1/S arrest
phenotype in response to ionising radiation and exhibit a greater
accumulation of cells in G2/M with a concomitant reduction of
the number of cells in both G1 and S phase, typical of a mutated
p53 response (Kuerbitz et al, 1992). SU-DHL-4 cells were also
more resistant to radiation-induced apoptosis than the DoHH2
cell line (data not shown). Immunoblotting confirmed the rapid
radiation-induced changes in stabilisation of p53 in DoHH2 but
not in SU-DHL-4.
Taxol induces a G2/M arrest in both DoHH2 and SU-DHL-4
To establish the general characteristics of the cell-cycle response to
taxol, cells were exposed to taxol at varying concentrations in the
clinically relevant low-dose range 1–20nM (Huizing et al, 1993).
The preparation method for cell-cycle analysis does not require
cell washing and, therefore, provides a high degree of retention of
both apoptotic and mitotic nuclei (Smith et al, 2000b). Figure 2
shows typical DNA histograms obtained from both cell lines
following treatment with 10nM taxol. At 9h following addition of
taxol both cell lines exhibit an accumulation of cells in G2/M, this
accumulation being more pronounced in the DoHH2 cell line, with
43% of the cells being in G2/M as opposed to 30% of the SU-DHL-4
line. Following 24h of exposure to taxol, the majority of the
DoHH2 cells (58%) remain in a cell-cycle arrest. In the SU-DHL-4
line however, only 10% of cells were retained in G2/M with the
majority of cells appearing to have progressed to a polyploid
generation demonstrating aberrant DNA contents. Thus, it appears
that both cell lines are responding to taxol by showing
compromised traverse of G2/M with cell-cycle arrest evident in
DoHH2, whereas the duration of any arrest appears to be greatly
reduced in the SU-DHL-4 (TP53-mutant) cell line.
Deconvolution of DNA content distributions obtained from
cultures exposed to varying concentrations of taxol over a 24h
time period permitted the plotting of the kinetics of cell-cycle
perturbation induced by taxol (Figure 3). Both DoHH2 and SU-
DHL-4 respond to taxol by a dose-dependent arrest in G2/M, with
a concomitant reduction of the fraction of cells in both the G1 and
S phase. The results indicate that taxol elicits a cell-cycle arrest in
DoHH2 cells at concentrations of 5, 10, and 20nM, and that this
arrest is substantially maintained during the period of exposure to
the drug. Although the same concentrations of taxol induce a cell-
cycle arrest in SU-DHL-4, the magnitude of this arrest is reduced
compared to that for the DoHH2 line. Linear regression analysis of
the data indicated that DoHH2 and SU-DHL-4 both exhibited a
near maximal rate of accumulation in G2/M following exposure to
20nM taxol, with rates of accumulation being 2.8 and 2.2% per h,
respectively. These rates of accumulation were maintained for
approximately 20h, that is, approximately one full cell-cycle
Figure 1 Differential cell-cycle arrest in response to ionising radiation.
DNA distributions are (A) DoHH2 and (B) SU-DHL-4 under normal
exponential growth conditions, and obtained 14h following exposure to
4Gy of ionising radiation (C) DoHH2, (D) SU-DHL-4. Data are
representative distributions obtained from 6000 cells. (E) SDS–PAGE
followed by immunoblotting for p53, analysis of cellular lysates from the
two cell lines prepared at the indicated time points after irradiation at 6Gy.
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straverse period. However, an analysis of the DNA distributions
(see Figure 2) indicates that at later time points (410h), both cell
lines show evidence of progression to polyploidy, therefore the
data plotted as G2/M will also contain G1 polyploid cells.
Thus, following taxol-induced cell-cycle arrest there are three
possible outcomes for the cell depending on the dose of drug to
which they are exposed. At low doses, cells may escape cell-cycle
arrest and continue cycling normally. At higher doses, cells may
experience a sustained cell-cycle arrest, or alternatively cells may
breach the cell-cycle arrest and proceed to polyploidy. These three
possible cell-cycle arrest events provide the key decision points
that determine whether a cell subsequently survives the cytotoxic
insult by taxol or proceeds to a programmed cell death (see
Figure 10).
Taxol induces a sustained cell-cycle arrest in DoHH2 cells
and a transient arrest in SU-DHL-4 cells
The differential pattern of cell-cycle arrest between the two cell
lines was confirmed by dual parameter measurements of the
mitosis-specific protein MPM2 vs DNA content (Figure 4). It can
be seen that following an 8h exposure to 10nM taxol, both cell
lines show evidence of a subpopulation of MPM2-positive cells.
However, this subpopulation is reduced in the SU-DHL-4 line as
compared to the DoHH2 line. It is clear that following 24h
exposure to 10nM taxol, the majority of the DoHH2 cells remain
arrested in mitosis, while the majority of the SU-DHL-4 cells have
shown cycle progression and exhibit aberrant and polyploid DNA
contents, which was also demonstrated in the single parameter
DNA measurements (see Figure 2).
To confirm the observed differences in the duration of mitotic
arrest, we also measured cyclin B1 protein expression following
exposure to taxol. Cyclin B1 is primarily synthesised during G2
and is rapidly degraded at the end of mitosis (Pines and Hunter,
1989). Dual parameter flow cytometric measurements of cyclin B1
expression vs DNA content following 8h of exposure to taxol
consistently indicated that the percentage of cells expressing cyclin
B1 during G2/M was increased following exposure to all of the
concentrations of taxol tested (1, 2, 5, 10, 20nM) (Figure 5).
Following a 24h exposure to taxol however, the number of
SU-DHL-4 cells in G2/M expressing cyclin B1 was reduced, at all
drug concentrations. In contrast, levels in the DoHH2 line
remained similar to those obtained at 8h. This pattern of results
is consistent with the view that the SU-DHL-4 cells are escaping
cell-cycle arrest at the 24h measurement point. However, it is also
apparent that both cell lines exhibit increased cyclin B1 expression
at doses of taxol that did not induce a measurable G2/M arrest on
the basis of single parameter DNA measurements. Cyclin B1 is
known to be associated with microtubules (Jackman et al, 1995)
and our observations suggest that taxol-induced tubulin polymer-
isation, at concentrations insufficient to induce a cell-cycle arrest,
can stabilise cyclin B1 levels.
Figure 2 Differential G2/M arrest and progression to polyploidy in
DoHH2 and SU-DHL-4 following continuous exposure to taxol. Cells were
incubated with 10nM taxol for the indicated times.
Figure 3 Dose dependency of the kinetics of cell-cycle perturbation
induced in DoHH2 and SU-DHL-4 by continuous exposure to taxol at 2, 5,
10, or 20nM. DNA histograms were deconvoluted and the results plotted
as percentage of cells in each particular cell-cycle phase, G1 (’), S (n),
G2/M+G1 polyploid (K), relative to those of an untreated population. The
dotted line in each panel represents a linear regression analysis of the
G2/M curve. The rates (%/h) of accumulation in G2/M following exposure
to 1, 2, 5, 10, or 20nM taxol are: DoHH2=0.09, 0.11, 0.72, 2.55, 2.76;
SU-DHL-4=0.02, 0.17, 0.43, 1.01, 2.22.
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sTaxol induces aberrant mitoses in both DoHH2
and SU-DHL-4 cells
Confocal laser scanning microscopy was performed in order to
obtain high-resolution spatial information on tubulin structures
and associated chromatin condensation. The results confirmed
that taxol induced the formation of aberrant mitotic spindles with
a concomitant abnormal chromosome segregation in both cell
lines (Figure 6). All of the observed mitoses in DoHH2 or SU-DHL-
4 following exposure to taxol displayed abnormal mitotic spindles
and chromatin segregation. These abnormal mitoses were all first
cycle events and were similar in appearance for both the cell lines,
with the formation of a tripolar mitotic spindle being the pre-
dominant aberrant feature following exposure to taxol. In order to
confirm the lack of p53-dependency in these observations, we have
extended our studies to include observations of isogenic thyroid-
derived (K1E7) cell lines, which differ only in TP53 status (Wyllie
et al, 1999). Using a time-lapse microscopy approach, we have
confirmed that taxol induces similar first cycle abnormal mitoses
in both wild-type and mutant p53 backgrounds (data not shown).
Taxol induces cell-cycle arrest in both G2 and mitosis
Discrimination between G2 and M on the basis of dual parameter
side-scatter vs DNA content (Epstein et al, 1988) allowed us to
further clarify the taxol-induced accumulation of cells in G2/M.
This methodology detects a mitotic subpopulation that excludes
prophase cells and is based on light scatter changes associated
with nuclear chromosome condensation and the breakdown of
the nuclear membrane that defines the start of prometaphase
and continues through until telophase. Figure 7 illustrates the
differential accumulation of cells in G2 and mitosis based on this
discrimination, following exposure to taxol. It can be seen that
taxol induces an accumulation of cells in both G2 and M in both
the cell lines. However, in the SU-DHL-4 cell line, the number of
cells arrested during mitosis is greatly reduced compared to the
DoHH2 line, in agreement with the data presented in Figures 4 and
5. There is also an early and sustained increase in the number of
cells with a G2 DNA content. Analysis of single parameter DNA
histograms infers that SU-DHL-4 cells do not maintain a mitotic
arrest, but proceed to polyploidy. We therefore suggest that the
observed increase in the number of cells exhibiting a G2 DNA
content is composed both of cells experiencing a G2 delay and also
those cells that have undergone an abnormal mitotic exit and are
G1 polyploid (with 4N DNA content).
Taxol induces apoptosis in p53 wild-type and p53 mutant
lymphoma cells
Annexin-V–FITC labelling of DoHH2 and SU-DHL-4 cells indi-
cated that both cell lines respond to taxol in a dose-dependent
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Figure 4 Dual parameter measurement of the mitotic protein MPM2
expression vs DNA content obtained during normal exponential growth
(A) DoHH2, (D) SU-DHL-4, and following 8h exposure to 10nM taxol
(B) DoHH2, (E) SU-DHL-4, and following 24h exposure to 10nM taxol
(C) DoHH2, (F) SU-DHL-4. Data are representative distributions obtained
from 10000 cells.
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Figure 5 Changes in the percentage of cells expressing cyclin B1 (A)
SU-DHL-4 and (B) DoHH2 following either 8h (closed symbols) or 24h
(open symbols) of exposure to 0, 1, 2, 5, 10, 20nM taxol. Cells were
labelled with anticyclin B1 monoclonal antibody and analysed by flow
cytometry. Data shown from a representative analysis of 6000 cells.
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smanner by proceeding to apoptosis (Figure 8); however, the
response differs between the two cell lines. Thus, 5nM taxol elicits
over a 90% induction of apoptosis in the DoHH2 cell line during
the course of 72h exposure, whereas only approximately 20% of
the SU-DHL-4 line are induced to undergo apoptosis by 5nM taxol
over the same time period. Using these terms of reference, we can
state that the DoHH2 cell line is more ‘sensitive’ to taxol than the
SU-DHL-4 line.
One striking feature of the data is that it appears that the
time for onset of apoptosis for a given cell line (8h DoHH2; 24h
SU-DHL-4) following drug exposure is remarkably constant and
dose-independent, once an apoptotic threshold condition is
reached. We can interpret this observation as either a threshold
continuous exposure period that is required before cell death
occurs, or a fixed delay period (lag) that occurs after the initial
insult during which the apoptotic mechanism is engaged. It is
apparent from an examination of the data obtained following
exposure to 5nM taxol that a prior cell-cycle arrest per se is not a
prerequisite for the induction of apoptosis by this agent.
Following the initial delay period, once the apoptotic events start
to appear, the rate at which the apoptotic population expands with
time is remarkably similar for both cell lines and this rate appears
to reach a maximum of approximately 2% per h. For a P-value
o0.05, the correlation coefficients, r, for the rate of G2/M
accumulation vs the rate of appearance of apoptotic cells (annexin
positive) are 0.90 for DoHH2 and 0.93 for SU-DHL-4 (Figure 9).
This significant correlation suggests a causal link between the rate
at which cells arrive at mitosis (that may or may not comprise a
functional checkpoint) and the subsequent rate of apoptosis.
Although we have fitted a straight line for both data sets (because
of the number of data points), we recognise the possibility of more
complex relations between G2/M arrest and apoptosis. We suggest
that at low doses (1–5nM), although cells experience ‘mitotic
stress’, it is either insufficient to induce a complete cell-cycle arrest
Figure 6 Laser scanning confocal fluorescence images showing normal
chromatin segregation and mitotic spindle formation in DoHH2 (A and B)
and SU-DL-4 (C and D) cells and the aberrant chromosome distribution
and tripolar mitotic spindle formation induced by exposure to 20nM taxol
in DoHH2 (E and F) and SU-DHL-4 (G and H).
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(J) and mitosis (’) following exposure to taxol at 2, 5, 10, or 20nM.
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sor that many cells rapidly breach or exit this arrest. At higher
doses (20nM), both the rate of G2/M accumulation and apoptosis
may be reaching maximum levels. With these considerations aside,
the relation between the two events still holds, that is, the prior rate
of experience of a cell-cycle perturbation (experience of mitosis) is
influencing the subsequent rate of cell death in both the cell types.
DISCUSSION
This study has provided a detailed time analysis of cell-cycle
disruption following continuous exposure to low concentrations
(1–20nM) of taxol. Cell-cycle events have been correlated with the
onset and subsequent kinetics of cell death in two lymphoma cell
lines that differ in their capacity to execute rapidly apoptosis.
Importantly, the concentrations of taxol used were within the
clinically relevant range of achievable plasma drug concentrations
(Huizing et al, 1993) and were therefore at a level that mitotic
spindle-associated microtubules were preferentially targeted rather
Figure 9 Correlation analysis illustrating the relation between the rate of
appearance of annexin-positive cells and the rate of cell-cycle arrest in G2/
M for DoHH2 and SU-DHL-4.
3
Figure 8 Differential kinetics of the apoptotic response in DoHH2 and
SU-DHL-4 following continuous exposure to 0, 2, 5, 10, or 20nM taxol.
Key: Live DoHH2 (’), annexin-positive DoHH2 (K), live SU-DHL-4 (&),
annexin-positive SU-DHL-4 (J). The dotted lines in each panel represent
a linear regression analysis of the straight line region of the annexin-positive
curves. The rates of appearance of apoptotic cells following exposure to 0,
2, 5, 10, and 20nM taxol are as follows: DoHH2= 0.05, 0.02, 1.29, 1.84,
2.16; SU-DHL-4= 0.02,  0.03, 0.41, 1.71, 1.84.
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sthan the overall cytoskeleton-associated microtubule system
(Jordan et al, 1993). Nonlimiting doses of taxol permit cells to
escape cycle arrest, arising from spindle disruption, providing an
opportunity to track apoptotic engagement in potentially ther-
apeutically important subpopulations. Our hypothesis was that
although cell death may occur at different stages of progression
through mitosis and subsequent cell cycles (Allman and Smith,
2002), the overall kinetics of cell death will relate to the rate of
arrival at a ‘critical event window’ in the cell cycle. The results
suggest a direct relation between the rate of delivery to a late cell-
cycle stage and the subsequent kinetics of cell death. The results
also suggest that the net effectiveness of low doses of taxol will be
driven primarily by the proliferation kinetics of a tumour cell
population despite any differential capacity to rapidly engage cell
death pathways as a consequence of genetic status. The findings
underline the importance of tracking event resolution over a
sufficiently long period to obtain an accurate determination of net
effect. Furthermore, our multiparameter analyses of the kinetics of
taxol responses in cells with differential capacity to rapidly engage
cell death may indicate new rationales for combining taxol with
other anticancer agents.
Microtubules are intrinsically dynamic polymers (Wilson and
Jordan, 1995) and previous reports have suggested that treatment
with high concentrations of taxol induces a cell-cycle arrest
in mitosis (Schiff and Horwitz, 1980), which is associated with
an increased microtubule polymer mass (Jordan et al, 1993).
However, treatment of cells with low concentrations of taxol
(10nM) has been suggested to induce a mitotic block by
suppressing microtubule dynamics rather than by altering the
microtubule polymer mass or inducing bundle formation (Jordan
et al, 1993). This suggests that the nature of the stress experienced
during mitosis, even under conditions of minimal mitotic delay
(SU-DHL-4), may be associated with a critical impact of altered
microtubule dynamics during mitosis rather than spindle check-
point activation per se.
That p53 plays an important role in the initiation and extent of
arrest of cell-cycle progression following DNA damage is now well
established (Kastan et al, 1991; Kuerbitz et al, 1992). The
contribution of damage surveillance mechanisms, including wild-
type p53, to cell survival following exposure to antitubulin agents
is not clear (see the introductory paragraphs), although p53
protein appears to participate in the spindle checkpoint to ensure
correct DNA replication before mitosis (Cross et al, 1995). p53 has
been reported to be a microtubule-associated protein (Maxwell
et al, 1991) and this raises the possibility that p53 is able to
monitor the status of microtubules directly. Aberrant p53 function
can suppress apoptosis following DNA damage resulting in a
phenotype that is both radiation- and chemoresistant. In contrast,
a number of reports have suggested that loss of wild-type p53
function sensitises cells to the action of taxol resulting in both
increased G2/M arrest and increased apoptosis.
Formal analysis of p53 involvement in taxol responses will
require the analysis of isogenic lines with differential p53
expression and these studies are in progress. Here, we have
concentrated on the more specific low-dose effects in a kinetically
matched system accessible to high-resolution analysis. Impor-
tantly, overall apoptotic kinetics have been appreciated by
extended tracking of treated cultures.
These results are in agreement with previous reports that
continued DNA replication, in permissive cells, in the presence of
mitotic spindle inhibitors results in a drive to polyploidy and
abnormal mitotic exit (Jordan et al, 1996; Di Leonardo et al, 1997).
The G1/S competence of DoHH2 may contribute to a postmitotic
G1 arrest in agreement with previous studies (Khan and Wahl,
1998; Notterman et al, 1998). The development of polyploidy
has also been associated with increasing taxol resistance in leu-
kaemia cell lines (Roberts et al, 1990). Abnormal mitotic spindle
formation prior to the development of polyploidy was confirmed
in the present study by confocal microscopy. In both cell lines
a similar range of aberrations were observed, with the presence
of tripolar spindles being a predominant feature. Confirming
studies (data not shown) using a different cell type (Wyllie et al,
1999) also revealed a p53-independence of the formation of
such aberrant spindles and mitoses for isogenic thyroid-derived
K1E7 cells.
The cell lines have similar cell-cycle kinetics, but differential
apoptotic responses (Smith et al, 1994, 2002). However, a striking
feature apparent in the current data is that there is a fixed delay
period prior to the onset of apoptosis, which is constant within a
given cell line irrespective of taxol dose. Our imaging studies
indicate that it is unlikely that the differences in this delay period
for the two cell lines relate to differences in the ability of taxol to
effect microtubule disruption per se. Total exposure time to taxol
appears to be less important than whether cells deliver to a critical
cell-cycle event during exposure. After this critical event, apoptotic
response rate is clearly dose-dependent. It is reasonable to suggest
that overt expression of apoptosis merely takes longer in SU-DHL-
4 cells. There is a significant correlation (Po0.05) between the rate
of accumulation of cells in G2/M and the rate of increase of the
number of apoptotic cells within the population and this
observation is consistent with the hypothesis that the rate at
which cells experience mitotic stress determines the subsequent
rate of cell death.
We propose a hierarchy of events in the cellular response to
taxol (Figure 10). Cells exposed to low concentrations of taxol may
undergo a mitotic arrest either by checkpoint activation or by
mechanical disruption of microtubules. We also incorporate the
possibility that stress-activated protein kinase activity can signal
mitotic arrest directly (Wang et al, 2000). Cells may subsequently
proceed to apoptosis directly (which is rapid) or, in cells that are
not subject to a cell-cycle arrest in mitosis, may proceed to
undergo a delayed induction of apoptosis that follows aberrant
mitotic exit and the formation of polyploid cells.
The mitotic spindle assembly checkpoint has been proposed to
regulate taxol-induced apoptosis, with the checkpoint component
Figure 10 Proposed model of taxol-induced cell death (incorporating
concepts from Wang et al, 2000) in which cells may either undergo a rapid
engagement of apoptosis during mitotic arrest or a delayed engagement of
apoptosis following aberrant mitotic exit.
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sBub1 being rapidly phosphorylated following taxol treatment
(Taylor et al, 2001). Importantly, the taxol concentration used was
1000-fold higher than those used in the present report. Here, we
have demonstrated that a prior cell-cycle arrest in mitosis is not
required for subsequent progression to apoptosis, that is, cell
death can be induced at lower concentrations than those required
for cell-cycle arrest. This suggests that taxol can trigger apoptosis
without the intervention of spindle checkpoint activation, but still
requires cells to experience traverse of the corresponding cell-cycle
stage under altered microtubule dynamics.
The potentially wide time course over which apoptotic events
may be triggered (upto 48h) provides few opportunities to
correlate biochemical assays with cellular events in heterogenously
responding populations monitored here. The antiapoptotic
protein survivin has been demonstrated to control microtubule
stability and assembly of mitotic spindles and can act to over-
ride apoptosis induced by taxol (Li et al, 1998; Giodini et al, 2002).
The relative expression of survivin in different cell systems
may therefore also contribute to observed differences in the
kinetics of response to taxol. Defining the kinetics of cellular
responses to taxol-induced stress in terms of checkpoint
activation, cell-cycle arrest, and apoptosis will contribute to a
coherent view as to how different agents with different cellular
targets may be combined with taxol to enhance therapeutic
effectiveness. This is of particular importance where combinations
of agents may abrogate taxol activity. We are currently investigat-
ing this approach using combinations of ionising radiation and
taxol.
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